EEG spectral exponent as a synthetic index for the longitudinal assessment of stroke recovery.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
05 2022
Historique:
received: 08 09 2021
revised: 02 01 2022
accepted: 22 02 2022
pubmed: 19 3 2022
medline: 20 4 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

Quantitative Electroencephalography (qEEG) can capture changes in brain activity following stroke. qEEG metrics traditionally focus on oscillatory activity, however recent findings highlight the importance of aperiodic (power-law) structure in characterizing pathological brain states. We assessed neurophysiological alterations and recovery after mono-hemispheric stroke by means of the Spectral Exponent (SE), a metric that reflects EEG slowing and quantifies the power-law decay of the EEG Power Spectral Density (PSD). Eighteen patients (n = 18) with mild to moderate mono-hemispheric Middle Cerebral Artery (MCA) ischaemic stroke were retrospectively enrolled for this study. Patients underwent EEG recording in the sub-acute phase (T0) and after 2 months of physical rehabilitation (T1). Sixteen healthy controls (HC; n = 16) matched by age and sex were enrolled as a normative group. SE values and narrow-band PSD were estimated for each recording. We compared SE and band-power between patients and HC, and between the affected (AH) and unaffected hemisphere (UH) at T0 and T1 in patients. At T0, stroke patients showed significantly more negative SE values than HC (p = 0.003), reflecting broad-band EEG slowing. Most important, in patients SE over the AH was consistently more negative compared to the UH and showed a renormalization at T1. This SE renormalization significantly correlated with National Institute of Health Stroke Scale (NIHSS) improvement (R = 0.63, p = 0.005). SE is a reliable readout of the neurophysiological and clinical alterations occurring after an ischaemic cortical lesion. SE promise to be a robust method to monitor and predict patients' functional outcome.

Identifiants

pubmed: 35303540
pii: S1388-2457(22)00193-6
doi: 10.1016/j.clinph.2022.02.022
pmc: PMC9038588
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-101

Informations de copyright

Copyright © 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Lancet Neurol. 2019 May;18(5):417-418
pubmed: 30871943
J Sleep Res. 2021 Oct;30(5):e13339
pubmed: 33769647
Brain. 2020 Dec 1;143(12):3672-3684
pubmed: 33188680
Nature. 2010 Nov 11;468(7321):305-9
pubmed: 21048709
Neural Plast. 2019 Sep 8;2019:1971875
pubmed: 31611914
J Neurosci Res. 2006 May 1;83(6):1077-87
pubmed: 16493681
Hum Brain Mapp. 2019 Feb 1;40(2):538-551
pubmed: 30259594
J Clin Neurophysiol. 2015 Jun;32(3):251-6
pubmed: 25350636
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jun;5(6):562-568
pubmed: 32340927
Physiother Res Int. 2019 Apr;24(2):e1764
pubmed: 30609208
Electroencephalogr Clin Neurophysiol. 1998 Mar;106(3):259-61
pubmed: 9743285
Neurosci Lett. 2019 Jul 27;706:88-92
pubmed: 31077739
Neurosci Lett. 1993 May 28;155(1):69-72
pubmed: 8361665
Neurophysiol Clin. 1998 Jun;28(3):249-57
pubmed: 9686400
Neuron. 2010 May 13;66(3):353-69
pubmed: 20471349
Clin Neurophysiol. 2008 Jul;119(7):1690-4
pubmed: 18450505
PLoS Comput Biol. 2009 Dec;5(12):e1000609
pubmed: 20019800
Cogn Neurodyn. 2009 Mar;3(1):97-103
pubmed: 19003455
Clin Neurophysiol. 2013 Jan;124(1):10-9
pubmed: 22858178
Stroke. 2004 Jul;35(7):e346-8
pubmed: 15155966
PLoS Comput Biol. 2016 Aug 10;12(8):e1005048
pubmed: 27509209
Mol Psychiatry. 2019 Sep;24(9):1248-1257
pubmed: 31089192
Nat Rev Neurosci. 2003 Sep;4(9):739-51
pubmed: 12951566
Stroke. 1994 Nov;25(11):2204-9
pubmed: 7974546
Nat Neurosci. 2020 Dec;23(12):1655-1665
pubmed: 33230329
Arch Neurol. 1988 May;45(5):520-4
pubmed: 3358704
Comput Intell Neurosci. 2011;2011:156869
pubmed: 21253357
Clin EEG Neurosci. 2004 Jul;35(3):116-24
pubmed: 15259617
Stroke Res Treat. 2012;2012:584727
pubmed: 23050198
Trends Cogn Sci. 2014 Sep;18(9):480-7
pubmed: 24788139
Neural Regen Res. 2019 Jul;14(7):1237-1246
pubmed: 30804255
IEEE Trans Biomed Eng. 2006 Dec;53(12 Pt 1):2583-7
pubmed: 17153216
Neuropharmacology. 2008 Sep;55(3):319-33
pubmed: 18314146
Clin Neurophysiol. 2003 Feb;114(2):199-209
pubmed: 12559226
Brain Stimul. 2017 Jul - Aug;10(4):721-734
pubmed: 28385535
J Neurosci. 2014 May 21;34(21):7137-47
pubmed: 24849349
Int J Mol Sci. 2015 Oct 26;16(10):25605-40
pubmed: 26516838
Arch Neurol. 2012 Feb;69(2):161-7
pubmed: 21987395
J Clin Neurophysiol. 2008 Apr;25(2):77-82
pubmed: 18340268
Brain Topogr. 2016 Jan;29(1):13-26
pubmed: 26318848
J Comput Neurosci. 2010 Dec;29(3):405-21
pubmed: 20697790
Clin Electroencephalogr. 2000 Oct;31(4):165-9
pubmed: 11056837
Neuroimage. 2017 Sep;158:70-78
pubmed: 28676297
Neurosci Lett. 1998 Jul 3;250(2):91-4
pubmed: 9697926
Neurohospitalist. 2016 Jul;6(3):97-101
pubmed: 27366291
J Neurophysiol. 2016 Feb 1;115(2):628-30
pubmed: 26245320
Front Physiol. 2012 Jun 15;3:186
pubmed: 22715328
Sleep. 2018 Oct 1;41(10):
pubmed: 30165388
Eur J Neurosci. 2021 Apr;53(7):2205-2213
pubmed: 32141151
J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2280-2286
pubmed: 31174955
Clin Neurophysiol. 2016 Feb;127(2):1452-1459
pubmed: 26251106
Front Hum Neurosci. 2017 Jul 28;11:385
pubmed: 28804453
Clin Neurophysiol. 2019 May;130(5):856-862
pubmed: 30902439
Nat Rev Neurol. 2014 Oct;10(10):597-608
pubmed: 25201238
Clin Neurophysiol. 2006 Mar;117(3):572-89
pubmed: 16442345
Restor Neurol Neurosci. 2013;31(2):177-88
pubmed: 23254689
Mol Autism. 2021 Feb 25;12(1):17
pubmed: 33632320
J Neurophysiol. 2016 Jun 1;115(5):2399-405
pubmed: 26936984
J Neurophysiol. 2020 May 1;123(5):1775-1790
pubmed: 32186435
Neuroimage. 2019 Apr 1;189:631-644
pubmed: 30639334
Brain Topogr. 2017 Sep;30(5):698-710
pubmed: 28547185
Neuroimage. 2021 Jul 1;234:117964
pubmed: 33771696
Brain Topogr. 2015 Sep;28(5):647-656
pubmed: 25998854
Nat Rev Neurosci. 2005 Mar;6(3):215-29
pubmed: 15738957
eNeuro. 2020 Dec 22;7(6):
pubmed: 32978216
Clin Neurophysiol. 2007 Nov;118(11):2525-32
pubmed: 17889600
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
J Cereb Blood Flow Metab. 1996 Sep;16(5):906-14
pubmed: 8784234

Auteurs

J Lanzone (J)

Neurorehabilitation Department, IRCCS Istituti Clinici Scientifici Salvatore Maugeri di Milano, 20138 Milan, Italy. Electronic address: jacopo.lanzone@gmail.com.

M A Colombo (MA)

Department of Biomedical and Clinical Sciences "L. Sacco", Università degli Studi di Milano, Italy.

S Sarasso (S)

Department of Biomedical and Clinical Sciences "L. Sacco", Università degli Studi di Milano, Italy.

F Zappasodi (F)

Department of Neuroscience, Imaging and Clinical Sciences and Institute for Advanced Biomedical Technologies, 'Gabriele d'Annunzio University, Chieti, Italy.

M Rosanova (M)

Department of Biomedical and Clinical Sciences "L. Sacco", Università degli Studi di Milano, Italy.

M Massimini (M)

Department of Biomedical and Clinical Sciences "L. Sacco", Università degli Studi di Milano, Italy; IRCCS, Fondazione Don Carlo Gnocchi, 20148 Milan, Italy.

V Di Lazzaro (V)

Università Campus-Biomedico di Roma, Neurology and Neurophysiology Unit, Italy.

G Assenza (G)

Università Campus-Biomedico di Roma, Neurology and Neurophysiology Unit, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH